Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 12 1995, 3124-3128, Vol 33, No. 12
L Sloan, S Schneider and J Rosenblatt
We evaluated a commercially available enzyme-linked immunoassay (ELISA)
from LMD Laboratories, Inc., Carlsbad, Calif., for the detection of
antibodies in serum to the cysticercus of Taenia solium. The ELISA was
performed on 308 serum samples; 198 from a pool of healthy individuals, 42
from patients who had antibodies against a variety of parasites other than
T. solium, and 68 from patients suspected of having cysticercosis. All of
these 68 specimens were tested both by the ELISA and by an immunoblot
method (enzyme-linked immunoelectrotransfer blot assay [EITB]) developed at
the Parasitic Serology Laboratory of the Centers for Disease Control and
Prevention. Twenty-seven of the 68 serum samples from patients suspected of
having cysticercosis were positive by both EITB and ELISA, while 31 were
negative by both assays. ELISA results for three and two samples were
considered false positive and false negative, respectively, when compared
with the results of EITB. Results for an additional five samples were
considered equivocal but were technically positive because their optical
density readings were slightly above the cutoff value. Three of the 198
serum samples from the bank of serum samples from healthy individuals were
also false positive by ELISA (the EITB result for the samples was
negative). Six other serum samples from healthy individuals which had
equivocal results and the five serum samples from patients with equivocal
results were EITB negative. Serum samples containing antibodies against
Echinococcus spp. frequently cross-reacted with the cysticercus ELISA
antigen (13 of 16 specimens), but serum samples with antibodies against
other parasites did not (2 of 26 specimens); all of these serum samples
were EITB negative. The commercially available ELISA that we describe is a
simple and rapid test. Considering all 308 specimens, the ELISA had a
specificity of 93% (when samples with equivocal results were considered
negative) or 89% (when samples with equivocal results were considered
positive); the sensitivity was 93%.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Evaluation of enzyme-linked immunoassay for serological diagnosis of cysticercosis
Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota 55905, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|